Literature DB >> 27879556

Who Gets Severe Gynecomastia Among HIV-infected Children in the United Kingdom and Ireland?

Julia Kenny1, Katja Doerholt, Di M Gibb, Ali Judd.   

Abstract

There are few data on gynecomastia in HIV-infected children. Within the UK/Ireland's national cohort, 56 of 1873 (3%) HIV-infected children had gynecomastia, of which 10 (0.5%) were severe. All 10 had received antiretroviral therapy for a median of 27.5 (21, 42) months; 4 of 10 had received efavirenz, 7 of 10 and 6 of 10 had received stavudine and/or didanosine respectively. Five were nonreversible, despite changing antiretroviral therapy, and required breast reduction surgery.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27879556      PMCID: PMC5929399          DOI: 10.1097/INF.0000000000001424

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  14 in total

1.  Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz.

Authors:  J A Caso; J de M Prieto; E Casas; J Sanz
Journal:  AIDS       Date:  2001-07-27       Impact factor: 4.177

2.  Gynaecomastia without lipodystrophy in HIV-1-seropositive patients on efavirenz: an alternative hypothesis.

Authors:  Nadeem A Qazi; John F Morlese; D Michael King; Rizvana S Ahmad; Brian G Gazzard; Mark R Nelson
Journal:  AIDS       Date:  2002-02-15       Impact factor: 4.177

3.  Breast enlargement in 13 men who were seropositive for human immunodeficiency virus.

Authors:  Devon L Evans; Liron Pantanowitz; Bruce J Dezube; David M Aboulafia
Journal:  Clin Infect Dis       Date:  2002-10-14       Impact factor: 9.079

4.  True gynecomastia in congenitally HIV-infected children treated with antiretroviral agents.

Authors:  R Manfredi; L Calza; F Chiodo
Journal:  J Chemother       Date:  2004-06       Impact factor: 1.714

Review 5.  Drug-induced gynecomastia.

Authors:  Ari Eckman; Adrian Dobs
Journal:  Expert Opin Drug Saf       Date:  2008-11       Impact factor: 4.250

Review 6.  Efavirenz-associated gynecomastia: report of five cases and review of the literature.

Authors:  Francisco Jover; José M Cuadrado; Pablo Roig; Marta Rodríguez; Lucio Andreu; Jaime Merino
Journal:  Breast J       Date:  2004 May-Jun       Impact factor: 2.431

7.  Severe gynecomastia in an African boy with perinatally acquired human immunodeficiency virus infection receiving highly active antiretroviral therapy.

Authors:  Agnieszka Dzwonek; Margaret Clapson; Simon Withey; Alan Bates; Vas Novelli
Journal:  Pediatr Infect Dis J       Date:  2006-02       Impact factor: 2.129

8.  Gynecomastia in HIV-infected patients receiving antiretroviral therapy.

Authors:  Teresa García-Benayas; Francisco Blanco; Luz Martín-Carbonero; Eulalia Valencia; Ana Barrios; Juan González-Lahoz; Vincent Soriano
Journal:  AIDS Res Hum Retroviruses       Date:  2003-09       Impact factor: 2.205

9.  Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care.

Authors:  Ali Judd; Katja Doerholt; Pat A Tookey; Mike Sharland; Andrew Riordan; Esse Menson; Vas Novelli; E G Hermione Lyall; Janet Masters; Gareth Tudor-Williams; Trinh Duong; Di M Gibb
Journal:  Clin Infect Dis       Date:  2007-08-27       Impact factor: 9.079

10.  Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.

Authors: 
Journal:  Lancet       Date:  2013-03-07       Impact factor: 79.321

View more
  2 in total

1.  Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?

Authors:  Elke Wynberg; Eleri Williams; Gareth Tudor-Williams; Hermione Lyall; Caroline Foster
Journal:  Clin Drug Investig       Date:  2018-03       Impact factor: 2.859

2.  Breast abnormalities in adolescents receiving antiretroviral therapy.

Authors:  Jackie L Dunlop; Wiedaad Slemming; Kathryn Schnippel; Caroline Makura; Leon J Levin; Sarah Rayne; Marnie Vujovic; Cynthia Firnhaber
Journal:  South Afr J HIV Med       Date:  2019-11-06       Impact factor: 2.744

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.